Company Overview and News

Gold extends gains on dovish Fed stance

14h thehindubusinessline
Spot gold had edged up 0.1 per cent to $1,293.93 per ounce by 0612 GMT, after gaining nearly 0.2 per cent in the previous session

NCLAT admits lenders’ plea over surrender of Jaypee land

14h livemint
New Delhi: The National Company Law Appellate Tribunal (NCLAT) on Thursday admitted an appeal moved by ICICI Bank Ltd and other lenders challenging an order passed by National Company Law Tribunal’s (NCLT) Allahabad bench directing Jaiprakash Associates Ltd (JAL) to return 759 acres of land to its unit Jaypee Infratech Ltd (JIL).

Barclays-Standard Chartered? I Can’t Even… - WSJ

2018-05-23 wsj
When an activist investor comes knocking, boards like to look busy—particularly if the activist is directly funded by a handful of your existing shareholders.

Barclays and Standard Chartered merger speculation gets a cool reception

The City has questioned the rationale of any mega-merger between Barclays and FTSE 100 banking rival Standard Chartered, following speculation that Barclays was considering merger options.

Deals of the day-Mergers and acquisitions

2018-05-23 reuters
May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:

UPDATE 1-UK Stocks-Factors to watch on May 23

2018-05-23 reuters
May 23 (Reuters) - Britain’s FTSE 100 index is seen opening 19 points lower at 7,858 on Wednesday, according to CMC Markets, with futures down 0.46 percent ahead of the cash market open.

Barclays is reportedly looking at a potential merger with Standard Chartered

2018-05-23 cnbc
Barclays has spoken to its rival bank Standard Chartered about a potential merger but no formal or informal bid was made, the Financial Times reported on Wednesday, citing two unnamed sources.

Fingerprint-based payments provider Touche inks deal with OCBC - Channel NewsAsia

2018-05-23 channelnewsasia
SINGAPORE: Merchants with OCBC Bank could soon have the option of offering a fingerprint-based payments and loyalty programme system to its customers.

Why Hong Kong homebuyers should take note if city’s aggregate balance dips below HK$100 billion

2018-05-22 scmp
With several indicators suggesting Hong Kong dollar liquidity is becoming tighter, banks’ higher borrowing costs could translate into higher mortgage repayments for homeowners

Phillips 66 Is Cashing In On The Oil Spread

2018-05-21 seekingalpha
The refining company can take advantage of the $8 differential between West Texas Intermediate crude oil and Brent crude.

Standard Chartered PLC - Updates

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Trump Expected to Follow Through on Threat to Impose China Tariffs - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Top Image Systems' (TISA) CEO Brendan Reidy on Q4 2017 Results - Earnings Call Transcript

2018-05-17 seekingalpha
Top Image Systems Ltd (NASDAQ:TISA) Q4 2017 Earnings Conference Call May 17, 2018 10:00 AM ET

Tata Steel said to seek loan for Bhushan Steel asset purchase

2018-05-17 livemint
Mumbai: Tata Steel Ltd. is preparing a Rs11,500 crore ($1.7 billion) loan to help fund its purchase of assets from Bhushan Steel Ltd., people familiar with the matter said.

Egypt's Banque Misr hires Citi for $500 mln loan -sources

2018-05-17 reuters
DUBAI (Reuters) - Banque Misr, Egypt’s second largest bank, has mandated Citigroup (C.N) to arrange a $500 million syndicated loan, banking sources said, the latest sign of a pick-up in interest among international banks in lending to Egyptian borrowers.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...